Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sándor Eckhardt

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Orvosi Hetilap|June 1, 2005
[Clinical studies with imatinib in 2004]Sándor Eckhardt
The Journal of Laboratory and Clinical Medicine|March 1, 2006
Molecular targeted therapy: a strategy of disillusions or optimism?Sándor Eckhardt
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Recent progress in the development of anticancer agentsSándor Eckhardt
Magyar Onkologia|September 17, 2003
[Perspectives for the hormonal therapy of breast cancer]Sándor Eckhardt
Pathology Oncology Research : POR|January 1, 1997
Molecular Events as Targets of Anticancer Drug TherapyAdorján Aszalós, Sándor Eckhardt
Magyar Onkologia|September 28, 2010
[Pharmaceutical therapy of breast cancer]István Láng, Zsuzsanna Kahán, Tamás Pintér, et al.
Magyar Onkologia|September 1, 2016
[Systemic therapy of breast cancer: practice guideline]Zsolt Horváth, Katalin Boér, Magdolna Dank, et al.
Pathology Oncology Research : POR|December 15, 2010
Inflammatory breast cancer-comparing the effectivity of preoperative docetaxel-epirubicine protocol to conventional antracycline-containing chemotherapy to achieve clinical benefit and complete pathological responseZsolt Horváth, László Torday, Erika Hitre, et al.
Orvosi Hetilap|December 23, 2003
[Effect of imatinib treatment of gastrointestinal stromal tumors]Sándor Eckhardt, Zsuzsanna Pápai, György Bodoky, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Orvosi Hetilap|June 1, 2005
[Clinical studies with imatinib in 2004]Sándor Eckhardt
The Journal of Laboratory and Clinical Medicine|March 1, 2006
Molecular targeted therapy: a strategy of disillusions or optimism?Sándor Eckhardt
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Recent progress in the development of anticancer agentsSándor Eckhardt
Magyar Onkologia|September 17, 2003
[Perspectives for the hormonal therapy of breast cancer]Sándor Eckhardt
Pathology Oncology Research : POR|January 1, 1997
Molecular Events as Targets of Anticancer Drug TherapyAdorján Aszalós, Sándor Eckhardt
Magyar Onkologia|September 28, 2010
[Pharmaceutical therapy of breast cancer]István Láng, Zsuzsanna Kahán, Tamás Pintér, et al.
Magyar Onkologia|September 1, 2016
[Systemic therapy of breast cancer: practice guideline]Zsolt Horváth, Katalin Boér, Magdolna Dank, et al.
Pathology Oncology Research : POR|December 15, 2010
Inflammatory breast cancer-comparing the effectivity of preoperative docetaxel-epirubicine protocol to conventional antracycline-containing chemotherapy to achieve clinical benefit and complete pathological responseZsolt Horváth, László Torday, Erika Hitre, et al.
Orvosi Hetilap|December 23, 2003
[Effect of imatinib treatment of gastrointestinal stromal tumors]Sándor Eckhardt, Zsuzsanna Pápai, György Bodoky, et al.
Pageof 1